To support NuVivant, Bien-Etre offers the region’s first at-home NAD+ Intracellular Test Kit, making it simpler for individuals to measure their cellular NAD+ levels without the hassle of visiting a clinic. A small blood sample is collected at home and processed in CLIA-certified partner labs in the US, providing accurate insights into cellular energy status and aging markers. Results are delivered digitally, allowing users to track their NAD+ levels over time and adjust their supplement plan through the personalised membership model.

By enabling people to track their NAD+ levels at home, Bien-Etre ensures that supplements are not just taken, but tailored and monitored to each individual. The monthly membership plan ensures that customers receive an at-home testing kit, which is returned to the lab once finished. The direct supplement is then delivered to the customer’s door based on the results, thus making longevity support both personalised and accessible. The membership model continues to deliver supplements monthly, making it easier than ever to integrate longevity-focused solutions into daily life with key and noticeable results.

Dubai has rapidly become a global hub for health, wellness, and innovation, making it the ideal location for the regional debut. The Middle East is seeing a surge in interest from health-conscious consumers eager to embrace biohacking and longevity solutions, while corporates in the region are increasingly seeking advanced wellness initiatives. This brand new offering from Bien-Etre addresses both audiences with tools that combine diagnostics, supplements, and technology. Looking ahead, Bien-Etre will expand its portfolio with a Longevity Screening Plan in 2026 and a Live Skin Age Tracking Tool by Summer 2026. These will complement the already-available SkinScreen AI Tool, a digital solution that allows users to assess their skin health online. Together, these innovations reflect the company’s commitment to blending diagnostics, AI, and genomics to help people live longer, healthier lives.

Bien-Etre was founded by Aly Rahimtoola, who after a decade of building a traditional skincare brand realised that the standard “one-size-fits-all” approach was not effective in addressing individual needs. Further research confirmed that this limitation extended beyond skincare to all aspects of wellness and lifestyle, catalysing the creation of Bien-Etre, a place where science and technology converge in perfect harmony, especially at a time when healthcare systems are increasingly strained. At the heart of the company’s philosophy lies a simple truth: individuals deserve care that is as unique as they are. Its dedicated team of scientists and product developers work passionately to translate complex genomic insights into practical, personalised solutions that deliver measurable results. The company believes the future of wellbeing is deeply personal, and that technology and data should be the first step on everyone’s path to lasting health and has selected the GCC region to launch as it sees the willingness of consumers and regulators to embrace technology and the future of health.